Briefing.com

Briefing.com Get the live stock market analysis, data, and investment ideas you need to stay fully informed. We provide independent, live market analysis of the U.S.

and international equity markets. It’s our passion, and has been since Dick Green, one of the most-recognized authorities in economic and financial market analysis, founded the Chicago-based company in 1992. We were the first company to use the power of the Internet to provide live market coverage, commentary and analysis. And as the Internet has grown, so have we. Our content now serves mil

lions of readers in 86 countries through our partnerships with virtually every leading online financial site and brokerage firm.

still has exposure to attractive power, utility, and data-center infrastructure themes, but the story has shifted from...
06/23/2026

still has exposure to attractive power, utility, and data-center infrastructure themes, but the story has shifted from secular growth to ex*****on risk. Investors need proof that the six troubled Renewables projects are a finite cleanup, not a broader structural issue. See the full analysis: https://www.briefing.com/story-stocks/archive/2026/6/23/primoris-services-power-surge-shorts-out-as-renewables-cost-overruns-trigger-guidance-cut-(prim)?utm_campaign=storystocks&utm_medium=social&utm_source=fb&utm_content=link $PRIM

Carnival’s demand backdrop remains strong, with record net yields, healthy bookings, and solid onboard spending. The iss...
06/23/2026

Carnival’s demand backdrop remains strong, with record net yields, healthy bookings, and solid onboard spending. The issue is earnings translation: higher fuel costs are limiting upside, making investors question how much of the cruise recovery can flow through to FY26 EPS. See the full analysis: https://www.briefing.com/story-stocks/archive/2026/6/23/carnival-cruises-past-q2-eps-estimates-but-guidance-leaves-investors-unimpressed-(ccl)?utm_campaign=storystocks&utm_medium=social&utm_source=fb&utm_content=link

is trading higher after agreeing to buy Apogee Therapeutics for $135.11/share in cash, valuing $APGE at about $10.9 bl...
06/22/2026

is trading higher after agreeing to buy Apogee Therapeutics for $135.11/share in cash, valuing $APGE at about $10.9 bln. The deal deepens ABBV’s immunology pipeline, but investors will be watching the price tag, clinical risk, and long path to EPS accretion. See the full analysis: https://www.briefing.com/story-stocks/archive/2026/6/22/abbvie-catches-apogee-fever-109b-deal-expands-immunology-and-asthma-pipeline?utm_campaign=storystocks&utm_medium=social&utm_source=fb&utm_content=link

's Arcosa deal adds scale in aggregates, infrastructure products, energy transmission, and grid modernization, fitting ...
06/22/2026

's Arcosa deal adds scale in aggregates, infrastructure products, energy transmission, and grid modernization, fitting its North American growth strategy. The debate is whether the company can justify the full valuation through synergies, accretion, deleveraging, and disciplined integration. See the full analysis: https://www.briefing.com/story-stocks/archive/2026/6/22/crh-slips-as-arcosa-deal-raises-questions-around-price-and-ex*****on-(crh)?utm_campaign=storystocks&utm_medium=social&utm_source=fb&utm_content=link

’s move reflects renewed value being placed on its role as a domestic foundry partner, especially if Apple becomes invo...
06/18/2026

’s move reflects renewed value being placed on its role as a domestic foundry partner, especially if Apple becomes involved. The debate is whether this becomes a meaningful commercial relationship or remains a sentiment-driven validation point until node, volume, and economics are confirmed. See the full analysis: https://www.briefing.com/story-stocks/archive/2026/6/18/intel-jumps-as-trumps-apple-comments-fuel-hopes-for-usbased-chip-manufacturing-tie-up-(intc)?utm_campaign=storystocks&utm_medium=social&utm_source=fb&utm_content=link

Fed Chair Warsh made clear that price stability is still the priority, pushing back against hopes for near-term cuts. Th...
06/18/2026

Fed Chair Warsh made clear that price stability is still the priority, pushing back against hopes for near-term cuts. The market is still rallying anyway, as lower oil, resilient jobless claims, semiconductor strength, and the AI buildout keep risk appetite alive. Read the premarket setup in today's Page One: https://www.briefing.com/page-one/archive/2026/6/18/market-plying-its-buythedip-trade-after-postfomc-selloff?utm_campaign=pageone&utm_medium=social&utm_source=fb&utm_content=link

Address

Oakbrook Terrace
Oakbrook Terrace, IL

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+18007523013

Website

, , ,

Alerts

Be the first to know and let us send you an email when Briefing.com posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category